AZ-LIMELIGHT-NETWORKS
17.9.2020 18:22:04 CEST | Business Wire | Press release
With online learning filling an unprecedented need to maintain educational opportunities worldwide, Limelight Networks, Inc. (Nasdaq: LLNW) , a leading provider of content delivery network (CDN) and edge cloud services, is helping EdTech companies worldwide provide content to parents, students and teachers.
The EdTech industry has been transformed almost overnight. In just a few months, remote learning has gone from a burgeoning business to a virtual lifeline for students and families everywhere. According to Limelight’s most recent global market research , 83 percent of those surveyed believe that video-based learning is here to stay. Companies all over the world have chosen Limelight to deliver these vital services, two of which are featured below:
Learning Ally , a leading nonprofit education organization, works with children who have reading challenges. Its Audiobook Solution offers an award-winning reading accommodation used in 18,500 schools. With the infrastructure and support of Limelight’s global private network, Ally was able to quickly absorb a wave of new subscribers and expand e-learning services. “In a matter of weeks, we added 13,800 educators and more than 130,000 new students to the Learning Ally Audiobook Solution. The Limelight CDN was able to support us in meeting the requirements for the surge of audiobook listeners,” said Cynthia Hamburger, CIO and COO at Learning Ally.
When schools closed during the pandemic in Canada, Groupe Média TFO (TFO), a French-language specialty channel, was tapped to create educational content for the online portal opened by its Minister of Education to serve more than 5 million school children. By leveraging the Limelight Video Platform to manage and distribute its online video at scale, TFO was able to quickly create and stream more content and handle a 60 percent increase in traffic during the stay-at-home order. “As a result of COVID-19, we had a very short turnaround to support the Ministry of Education’s learn-at-home initiative and play an important role in the move to online learning with our rich collection of educational videos. As we reached an unprecedented number of visits on our sites, we were hit with massive growth in bandwidth. Thankfully, our CDN infrastructure was built on Limelight, so we were not only ready, but we were also able to expand the initiative nationwide to support as many families and students as possible,” said Micaël N’Goran, Director, Solutions and Optimization at Groupe Média TFO.
“At Limelight, we’re passionate about delivering the highest quality online video and edge cloud services for customers across industries,” said Dan Carney, SVP of Network Operations at Limelight. “Serving all of our clients is satisfying, but supporting the educational needs of children, parents and educators globally during this difficult time is particularly motivating.”
To find out more on how Limelight is enabling EdTech clients, see here for detailed case studies.
About Limelight
Limelight Networks, Inc. (NASDAQ: LLNW), a leading provider of digital content delivery, video, cloud security, and edge computing services, empowers customers to provide exceptional digital experiences. Limelight’s edge services platform includes a unique combination of global private infrastructure, intelligent software, and expert support services that enable current and future workflows. For more information, visit www.limelight.com , follow us on Twitter , Facebook , and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005807/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom